Next 10 |
home / stock / idxx / idxx articles
Wednesday, IDEXX Laboratories Inc (NASDAQ:IDXX) reported first-quarter adjusted EPS of $2.81, up 10% Y/Y, beating the consensus...
IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 5 years by 5.0% on an annualized basis producing an average annual retur...
West Pharmaceutical Services, Inc. (NYSE: WST) reported first-quarter 2024 adjusted earnings per share (ETF:EPS) of $1.56, which beat the Zacks Con...
IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 20 years by 3.81% on an annualized basis producing an average annual ret...
IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 5 years by 7.8% on an annualized basis producing an average annual retur...
IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 15 years by 13.65% on an annualized basis producing an average annual re...
IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 15 years by 13.63% on an annualized basis producing an average annual re...
IDEXX Laboratories Inc (NASDAQ:IDXX) shares are trading higher after the company released better-than-expected fourth-quarter 2023 financ...
Looking into the current session, IDEXX Laboratories Inc. (NASDAQ:IDXX) shares are trading at $530.12, after a 0.97% decrease. Over the past month,...
News, Short Squeeze, Breakout and More Instantly...
IDEXX Laboratories Inc. Company Name:
IDXX Stock Symbol:
NASDAQ Market:
2024-05-18 09:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Brian McKeon, Executive Vice President and Chief Financial Officer, and Michael Lane, Executive Vice President, General Manager, Reference Laboratories and Information Technology, will part...
Wednesday, IDEXX Laboratories Inc (NASDAQ:IDXX) reported first-quarter adjusted EPS of $2.81, up 10% Y/Y, beating the consensus...